By Connor Hart

Hims & Hers Health beat fourth-quarter estimates and guided for better-than-expected revenue in the first quarter and 2025. The telehealth provider logged earnings of 11 cents a share on revenue of $481 million in the recent quarter, nearly doubling its results from last year's comparable frame. It forecast revenue of $2.3 billion to $2.4 billion in 2025. Its weight-loss business, though, could come under pressure after the FDA declared an end to the shortage of popular weight-loss drugs Wegovy and Ozempic and said compounding pharmacies supplying companies like Hims will need to stop making and selling knockoff drugs by May 22 at the latest. Shares fall 18%, to $42.30, in after-hours trading.

Chegg is conducting a review of its business and exploring alternatives, including a sale or privatization, as the provider of individualized learning support to students keeps losing subscribers to AI-enabled rivals. The company, which has hired Goldman Sachs as financial adviser for its review, also said it has filed a complaint in federal court against Google and its parent company Alphabet for allegedly blocking traffic from coming to Chegg. Shares decline 22%, to $1.22, in postmarket trading.

Wah Fu Education Group said it would integrate DeepSeek's artificial-intelligence model to its platform. The Chinese company, which provides online-education and exam-preparation services, said the model will provide AI-based assistants for many of its programs, allowing it to customize learning plans based on students' habits. This customization will help increase retention and improve learning, the company said. Shares climb 68%, to $3, in after-hours trading.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

February 24, 2025 18:49 ET (23:49 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.